ArticleMedicine2025
A bidirectional Mendelian randomization analysis of the causal relationship between immune cells and high-grade squamous intraepithelial lesion.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-grade squamous intraepithelial lesions (HSIL), critical precursors to cervical cancer, are associated with persistent human papillomavirus infection and immune dysregulation, yet the causal role of specific immune cell phenotypes remains unclear. To investigate bidirectional causal relationships, we performed a 2-sample Mendelian randomization (MR) analysis using European genome-wide association study data: 731 immune cell phenotypes and HSIL. Instrumental variables (P < 1 × 10⁻⁵) were selected under MR assumptions, with inverse-variance weighted as the primary method. Forward MR (immune cells to HSIL) identified 67 phenotypes nominally associated (P < .05); after FDR correction (FDR < 0.20), IgD on transitional B cells were protective, while increased CD3 on CD39+ Tregs elevated risk. Reverse MR (HSIL to immune cells) indicated HSIL causally reduces naïve CD4- CD8- T cell, HVEM on effector memory CD8+ T cells, FSC-A on lymphocyte and FSC-A on T cells (FDR < 0.20). This study provides genetic evidence for causal roles of specific immune phenotypes in HSIL pathogenesis, suggesting immunotherapeutic targets, while revealing HSIL-induced immune exhaustion patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.